DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
2020
4.4K+
LTM Revenue $429M
LTM EBITDA $6.1M
$115M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
DocGo has a last 12-month revenue (LTM) of $429M and a last 12-month EBITDA of $6.1M.
In the most recent fiscal year, DocGo achieved revenue of $617M and an EBITDA of $45.6M.
DocGo expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See DocGo valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $429M | XXX | $617M | XXX | XXX | XXX |
Gross Profit | $144M | XXX | $214M | XXX | XXX | XXX |
Gross Margin | 34% | XXX | 35% | XXX | XXX | XXX |
EBITDA | $6.1M | XXX | $45.6M | XXX | XXX | XXX |
EBITDA Margin | 1% | XXX | 7% | XXX | XXX | XXX |
EBIT | -$26.4M | XXX | $28.7M | XXX | XXX | XXX |
EBIT Margin | -6% | XXX | 5% | XXX | XXX | XXX |
Net Profit | -$21.5M | XXX | $20.0M | XXX | XXX | XXX |
Net Margin | -5% | XXX | 3% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, DocGo's stock price is $2.
DocGo has current market cap of $158M, and EV of $115M.
See DocGo trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$115M | $158M | XXX | XXX | XXX | XXX | $-0.22 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, DocGo has market cap of $158M and EV of $115M.
DocGo's trades at 0.2x EV/Revenue multiple, and 2.5x EV/EBITDA.
Equity research analysts estimate DocGo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
DocGo has a P/E ratio of -7.4x.
See valuation multiples for DocGo and 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $158M | XXX | $158M | XXX | XXX | XXX |
EV (current) | $115M | XXX | $115M | XXX | XXX | XXX |
EV/Revenue | 0.3x | XXX | 0.2x | XXX | XXX | XXX |
EV/EBITDA | 18.7x | XXX | 2.5x | XXX | XXX | XXX |
EV/EBIT | -4.3x | XXX | 4.0x | XXX | XXX | XXX |
EV/Gross Profit | 0.8x | XXX | n/a | XXX | XXX | XXX |
P/E | -7.4x | XXX | 7.9x | XXX | XXX | XXX |
EV/FCF | 1.8x | XXX | 1.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDocGo's last 12 month revenue growth is -26%
DocGo's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $42K for the same period.
DocGo's rule of 40 is -21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
DocGo's rule of X is -63% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for DocGo and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | -26% | XXX | -28% | XXX | XXX | XXX |
EBITDA Margin | 1% | XXX | 7% | XXX | XXX | XXX |
EBITDA Growth | -302% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | -21% | XXX | -18% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | -63% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $42K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DocGo acquired XXX companies to date.
Last acquisition by DocGo was XXXXXXXX, XXXXX XXXXX XXXXXX . DocGo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was DocGo founded? | DocGo was founded in 2020. |
Where is DocGo headquartered? | DocGo is headquartered in United States of America. |
How many employees does DocGo have? | As of today, DocGo has 4.4K+ employees. |
Who is the CEO of DocGo? | DocGo's CEO is Mr. Lee Bienstock. |
Is DocGo publicy listed? | Yes, DocGo is a public company listed on NAS. |
What is the stock symbol of DocGo? | DocGo trades under DCGO ticker. |
When did DocGo go public? | DocGo went public in 2021. |
Who are competitors of DocGo? | Similar companies to DocGo include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
What is the current market cap of DocGo? | DocGo's current market cap is $158M |
What is the current revenue of DocGo? | DocGo's last 12 months revenue is $429M. |
What is the current revenue growth of DocGo? | DocGo revenue growth (NTM/LTM) is -26%. |
What is the current EV/Revenue multiple of DocGo? | Current revenue multiple of DocGo is 0.3x. |
Is DocGo profitable? | Yes, DocGo is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of DocGo? | DocGo's last 12 months EBITDA is $6.1M. |
What is DocGo's EBITDA margin? | DocGo's last 12 months EBITDA margin is 1%. |
What is the current EV/EBITDA multiple of DocGo? | Current EBITDA multiple of DocGo is 18.7x. |
What is the current FCF of DocGo? | DocGo's last 12 months FCF is $64.9M. |
What is DocGo's FCF margin? | DocGo's last 12 months FCF margin is 15%. |
What is the current EV/FCF multiple of DocGo? | Current FCF multiple of DocGo is 1.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.